Eagle Pharmaceuticals (EGRX) Competitors $3.19 0.00 (0.00%) As of 08/25/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EGRX vs. BIOA, LFVN, HURA, CLYM, MEIP, FTLF, BTMD, CLLS, ELDN, and CRDFShould you be buying Eagle Pharmaceuticals stock or one of its competitors? The main competitors of Eagle Pharmaceuticals include BioAge Labs (BIOA), Lifevantage (LFVN), TuHURA Biosciences (HURA), Climb Bio (CLYM), MEI Pharma (MEIP), FitLife Brands (FTLF), biote (BTMD), Cellectis (CLLS), Eledon Pharmaceuticals (ELDN), and Cardiff Oncology (CRDF). These companies are all part of the "pharmaceutical products" industry. Eagle Pharmaceuticals vs. Its Competitors BioAge Labs Lifevantage TuHURA Biosciences Climb Bio MEI Pharma FitLife Brands biote Cellectis Eledon Pharmaceuticals Cardiff Oncology Eagle Pharmaceuticals (NASDAQ:EGRX) and BioAge Labs (NASDAQ:BIOA) are both small-cap pharmaceutical preparations industry companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends. Do institutionals and insiders believe in EGRX or BIOA? 85.4% of Eagle Pharmaceuticals shares are owned by institutional investors. 28.9% of Eagle Pharmaceuticals shares are owned by company insiders. Comparatively, 20.8% of BioAge Labs shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is EGRX or BIOA more profitable? Eagle Pharmaceuticals' return on equity of 0.00% beat BioAge Labs' return on equity.Company Net Margins Return on Equity Return on Assets Eagle PharmaceuticalsN/A N/A N/A BioAge Labs N/A -25.39%-23.22% Which has preferable valuation and earnings, EGRX or BIOA? Eagle Pharmaceuticals has higher revenue and earnings than BioAge Labs. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEagle Pharmaceuticals$257.55M0.16$35.64MN/AN/ABioAge Labs$3.86M43.99-$71.11MN/AN/A Does the media prefer EGRX or BIOA? In the previous week, BioAge Labs had 1 more articles in the media than Eagle Pharmaceuticals. MarketBeat recorded 1 mentions for BioAge Labs and 0 mentions for Eagle Pharmaceuticals. BioAge Labs' average media sentiment score of 0.93 beat Eagle Pharmaceuticals' score of 0.00 indicating that BioAge Labs is being referred to more favorably in the news media. Company Overall Sentiment Eagle Pharmaceuticals Neutral BioAge Labs Positive SummaryEagle Pharmaceuticals beats BioAge Labs on 6 of the 9 factors compared between the two stocks. Get Eagle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for EGRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EGRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EGRX vs. The Competition Export to ExcelMetricEagle PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$41.43M$904.02M$5.79B$9.78BDividend YieldN/A4.84%3.95%4.02%P/E RatioN/A1.1430.8326.37Price / Sales0.1626.63462.91121.31Price / Cash0.4019.5637.7659.36Price / BookN/A6.7710.106.62Net Income$35.64M-$4.20M$3.26B$265.42M7 Day PerformanceN/A3.05%2.77%3.08%1 Month PerformanceN/A3.71%3.94%0.77%1 Year Performance-38.65%20.84%43.03%22.97% Eagle Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EGRXEagle PharmaceuticalsN/A$3.19flatN/A-33.0%$41.43M$257.55M0.00100BIOABioAge LabsN/A$4.51-2.2%N/AN/A$165.27MN/A0.00N/ALFVNLifevantage3.9718 of 5 stars$12.89-1.5%$30.50+136.6%+53.3%$164.65M$200.16M18.68260News CoverageHURATuHURA Biosciences1.4937 of 5 stars$2.95-9.2%$12.67+329.4%N/A$162.65MN/A0.00N/ACLYMClimb Bio3.4056 of 5 stars$2.48+4.2%$9.00+262.9%N/A$161.28MN/A-3.549Gap UpMEIPMEI Pharma1.1111 of 5 stars$5.00+0.6%N/A+62.3%$160.87M$65.30M-1.05100Gap DownFTLFFitLife Brands3.6293 of 5 stars$18.20+7.1%$22.00+20.9%+12.9%$159.65M$63.05M21.6720Positive NewsBTMDbiote2.6709 of 5 stars$3.23+0.3%$6.00+85.8%-44.4%$159.19M$197.19M3.59194CLLSCellectis3.5007 of 5 stars$2.69-5.6%$4.00+48.7%+12.2%$158.41M$49.22M-3.28290Positive NewsGap DownELDNEledon Pharmaceuticals1.6176 of 5 stars$2.57-1.2%$10.00+289.1%-9.8%$155.69MN/A-2.2010CRDFCardiff Oncology2.1506 of 5 stars$2.21-4.7%$10.10+357.0%-7.3%$154.34M$545K-2.5420News Coverage Related Companies and Tools Related Companies BIOA Alternatives LFVN Alternatives HURA Alternatives CLYM Alternatives MEIP Alternatives FTLF Alternatives BTMD Alternatives CLLS Alternatives ELDN Alternatives CRDF Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EGRX) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump's "Big Beautiful Bill" hides ugly truthWashington’s new “Big Beautiful Bill” promises tax breaks… but the fine print tells a different story: trillio...Defi Master | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eagle Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eagle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access